# ESOMEPRAZOLE MAGNESIUM
> **ANDA216349** · Abbreviated New Drug Application (Generic) · Sponsor: GRAVITI PHARMS · Approved 2022-06-24
## Drug
- **FDA Application Number:** ANDA216349
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESOMEPRAZOLE MAGNESIUM
- **Generic name:** ESOMEPRAZOLE MAGNESIUM
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** GRAVITI PHARMS
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2022-06-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216349)
---
*MORVS · CC0 1.0*